<DOC>
	<DOC>NCT01155999</DOC>
	<brief_summary>Efficacy/Safety of T1225, in comparison to reference product, for the treatment of purulent bacterial conjunctivitis of children.</brief_summary>
	<brief_title>Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>Age ≥ one day of life and ≤ 18 years Purulent bacterial conjunctivitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>